Edit
Affivant
https://affivant.com/Last activity: 24.04.2026
Probably Closed - Reference to Roivant Sciences
Affivant is a company dedicated to developing novel immune-oncology approaches to activate and enable the innate immune system to fight cancer. Their innovative bi-specific innate cell engagers are designed to target specific patient populations as powerful monotherapies and combination treatments.
Location: Switzerland, Basel-City, Basel
Employees: 11-50
Investors 2
| Date | Name | Website |
| 25.03.2024 | VentureLab | venturelab... |
| - | Roivant | roivant.co... |
Mentions in press and media 2
| Date | Title | Description |
| 24.04.2026 | Ferrosa Therapeutics: $3.5 Million Seed Financing For Bispecific Antibody Targeting Anemia Of Inflammation | Ferrosa Therapeutics AG, a Swiss biotechnology company focused on treating anemia of inflammation, announced a $3.5 million seed financing round led by Forty51 Ventures. The funding will support the advancement of the company’s first-in-cla... |
| 19.04.2023 | Ten biotech startups head to Boston |